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Background: Diabetes has become a serious health problem and a major risk factor associated with troublesome
health complications, such as metabolism disorders and liver-kidney dysfunctions. The inadequacies associated with
conventional medicines have led to a determined search for alternative natural therapeutic agents. The present
study aimed to investigate and compare the hypoglycemic and antilipidemic effects of kombucha and black tea,
two natural drinks commonly consumed around the world, in surviving diabetic rats.
Methods: Alloxan diabetic rats were orally supplied with kombucha and black tea at a dose of 5 mL/kg body
weight per day for 30 days, fasted overnight, and sacrificed on the 31st day of the experiment. Their bloods were
collected and submitted to various biochemical measurements, including blood glucose, cholesterol, triglcerides,
urea, creatinine, transaminases, transpeptidase, lipase, and amylase activities. Their pancreases were isolated and
processed to measure lipase and α-amylase activities and to perform histological analysis.
Results: The findings revealed that, compared to black tea, kombucha tea was a better inhibitor of α-amylase and
lipase activities in the plasma and pancreas and a better suppressor of increased blood glucose levels. Interestingly,
kombucha was noted to induce a marked delay in the absorption of LDL-cholesterol and triglycerides and a
significant increase in HDL-cholesterol. Histological analyses also showed that it exerted an ameliorative action on
the pancreases and efficiently protected the liver-kidney functions of diabetic rats, evidenced by significant
decreases in aspartate transaminase, alanine transaminase, and gamma-glytamyl transpeptidase activities in the
plasma, as well as in the creatinine and urea contents.
Conclusions: The findings revealed that kombucha tea administration induced attractive curative effects on
diabetic rats, particularly in terms of liver-kidney functions. Kombucha tea can, therefore, be considered as a
potential strong candidate for future application as a functional supplement for the treatment and prevention
of diabetes.Background
Diabetes mellitus (DM) is a chronic metabolic disorder
that constitutes a major public health problem through-
out the world. Current estimates indicate that approxi-
mately 4% of the global population suffer from DM, a
percentage which is expected to reach 5.4% in 2025 [1].
This disease is a multifactor disorder associated with
chronic hyperglycemia and troublesome disruptions in
carbohydrate, fat, and protein metabolisms emanating
from deficiencies or disruptions in insulin secretion [2],* Correspondence: aloulou@u.washington.edu
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reproduction in any medium, provided the ordefects in reactive oxygen species scavenging enzymes
[3], and high oxidative stress impairing pancreatic beta cells
[4,5]. Hyperglycemia leads to long-term tissue damages
and complications, such as liver-kidney dysfunctions,
often associated with serious diseases [6,7].
The prevalence of type 2 diabetes mellitus is increasing
worldwide at alarming rates. Several therapeutic strategies
are currently available for the treatment of this chronic
metabolic disorder, including the stimulation of endogen-
ous insulin secretion, enhancement of insulin action at
the target tissues, inhibition of dietary starch and lipid
degradation, and treatment with oral hypoglycemic agents
[8]. The limitations associated with those therapeutic
strategies have led to a determined search for morel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been further intensified by increasing doubts surround-
ing current dietary and other lifestyle behaviors together
with growing interests in functional foods and nutraceu-
ticals [9]. Complementary and alternative medicine
applications have attracted special attention in recent
research for they offer new promising opportunities for
the development of efficient, side effect-free, and lower
cost alternatives to existing synthetic hypoglycemic
agents [10-12].
Of particular relevance to this argument, kombucha
tea (KT), a traditional drink made from a particular fer-
mentation of sugared black tea (BT) and a symbiosis of
yeast species, fungi, and acetic acid bacteria, is com-
monly consumed throughout the world as a medicinal
health-promoting beverage [13]. Although the beneficial
and/or adverse effects of kombucha tea on human health
have not been scientifically determined yet, there are
several reasons to believe that kombucha may have
desirable positive effects on human health. In fact, the
metabolic and health effects of several probiotic pro-
ducts are gathering increasing momentum in recent
years. A number of currently commercialized food pro-
ducts (e.g. yogurt, cheese, fermented vegetables and
kefir) are known to contain live bacteria, or metabolites
of bacteria, produced during similar fermentation
processes, and are considered as health promoting pro-
biotic foodstuffs [14,15]. Moreover, several studies have
recently demonstrated that kombucha can reduce cell
damage induced by oxidative stress [16-20]. Kombucha
has also been reported to constitute a potent therapeutic
supplement that improved resistance against cancer, pre-
vented cardiovascular diseases, promoted digestive func-
tions, stimulated the immune system, and reduced
inflammatory problems [17,21-23].
Tea and kombucha are presented in the literature as
two very distinct beverages and no correlation has so far
been reported between them [24]. Some of the effects
reported for kombucha intakes are, however, very similar
to those described for tea [24]. Nevertheless, while the
composition, properties, and effects of tea on chronic
and progressive illnesses, such as diabetes, are well
documented in the literature [25], little data are cur-
rently available on these issues with regards to kombu-
cha. In fact, most of the data on kombucha tea is
anecdotal and further studies are needed to elucidate its
putative therapeutic potential, particularly against DM.
In this context, pancreatic lipase, a complex enzyme
that plays a key role in lipid metabolism, has often been
employed in human and animal model studies involving
the evaluation of natural products for potential applica-
tion as antiobesity and antidiabetic agents [8]. The inhib-
ition of this enzyme significantly decreases the digestion
and uptake of lipids, thereby decreasing the level ofpostprandial blood glucose in non-insulin-dependent
diabetic patients. Pancreatic α-amylase is a key enzyme in
the digestive system that catalyses the initial step in the
hydrolysis of starch to a mixture of smaller oligosacchar-
ides consisting of maltose, maltotriose, and a number of
oligoglucans. These are then acted on by α-glucosidases
and further degraded to glucose that enters the blood-
stream. The degradation of this dietary starch proceeds
rapidly and leads to elevated postprandial hyperglycemia.
Inhibitors of pancreatic α-amylase delay carbohydrate
digestion, thus reducing glucose absorption rates and low-
ering postprandial serum glucose levels [26].
Considering the increasing concerns over the alarming
rates recorded for DM and in light of the promising
opportunities that kombucha might open with regards
to the alleviation and/or prevention of this troublesome
disease, the present study was undertaken to investigate
and assess the hypoglycemic and antilipidemic effects
of kombucha using a diabetic rat model. It aims to
gain principled insights with regards to the biological
activities of kombucha towards pancreatic lipase and
α-amylase as well as its effects on liver-kidney function,
which may provide a starting point for the understand-
ing of the antidiabetic potential of kombucha. For the
sake of pertinence, the biological activities of kombucha
were compared to those reported for black tea [27].
Methods
Black tea preparation
One hundred grams of sugar were added to 1 L of dis-
tilled water, and the solution was boiled for 15 min in a
sterile conical flask. Black tea powder (Lipton) was
added to the flask (12 g/L), which was then left to cool
down at room temperature for one hour. The mixture
was filtered using a sterile nylon mesh, and the filtrate
was used as black tea [17].
Kombucha preparation
The kombucha cultures employed in the present work
were purchased from a French commercial online outlet
(Kombucha-Shop). They are known as symbionts of
yeasts (e.g. Zygosaccharomyces, Schizosaccharomyces,
Torulospora, Rhodotorula, Brettanomyces, Candida,
Pichia, and Zygosaccharomyces) and bacteria (e.g. Aceto-
bacter) [17,28]. The cultures were stored at 4°C prior to
fermentation. Black tea was poured into 1-L glass jars,
which were sterilized beforehand, and inoculated with
2.5% (w/v) of freshly grown kombucha mat that had
been grown and maintained in the same medium [29].
The fermentation, kept under aseptic conditions, was
carried out by incubating the kombucha culture at
28 ± 1°C for 12 days. The flask was covered with clean
cheese cloth and fixed with rubber bands. The medium
(brew) was then centrifuged aseptically at 1500 × g for
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further use [17]. New kombucha mat developed over the
mother culture.
Animals and treatments
The experimental protocols and procedures used in the
present work were approved by the Ethics Committee of
the University of Sfax (Sfax, Tunisia) for the care and use
of laboratory animals. Adult male Wistar rats, weighing
179± 10 g, were obtained from the Central Pharmacy
(Tunisia). The animals were kept in an environmentally
controlled breeding room where they had free access to
tap water and pellet diet (Sico, Tunisia) [30].
Induction of diabetes
Diabetes was induced through a single intraperitoneal
injection of a freshly prepared alloxan (Sigma-Aldrich,
USA) solution in normal saline at a dose of 150 mg/kg
body weight. Since the injection of alloxan can provoke
fatal hypoglycemia due to a reactive massive release
of pancreatic insulin, the rats were also orally given 5–
10 ml of a 20% glucose solution after 6 h. The animals
were then kept with free access to 5% glucose solution
for the next 24 h to prevent severe hypoglycemia [31].
Two weeks later, the rats with moderate diabetes having
glycosuria and hyperglycemia (i.e. with blood glucose
levels of ≥2 g/l) were chosen for the experiments. They
were fasted overnight before being sacrificed by decapi-
tation for blood and tissue analyses.
Experimental design
The rats were subdivided into six experimental groups
of eight animals each. Each group was submitted to a
specific treatment as follows. Normal control and dia-
betic rats, referred to as [Con] and [Diab] groups,
respectively, were fed with normal diet and drinking
water ad libitum. Diabetic rats that received KT and BT by
gastric gavage (5 ml per kg of body weight) every day [5]
were designated as [Diab+KT] and [Diab+BT] groups,
respectively. Normal rats that were given KT and BT by
gastric gavage (5 ml per kg of body weight) every day were
termed as [Con+KT] and [Con+BT] groups, respectively.
One month later, the rats were weighed and sacrificed
by decapitation, and their trunk bloods were collected.
Plasma was immediately separated by centrifugation at
4°C and 1500 × g for 15 min. The pancreases were
removed and trimmed free of fat. The samples were
stored at −80°C until further use.
Biochemical study
The pancreas of each rat was excised and then homoge-
nized and centrifuged (5000 × g, 20 min, 4°C). The
supernatant was frozen and stored till further use in sub-
sequent enzymatic assays. Protein content was estimatedby the method described by Lowry et al. [32]. The activ-
ities of aspartate transaminase [26], alanine transami-
nase (ALT), gamma-glutamyl transpeptidase (GGT), and
α-amylase as well as the levels of glucose, urea, creati-
nine, total cholesterol, triglycerides (TG), and high-
density lipoprotein-cholesterol (HDL-Ch) in the serum
were measured using commercial kits from Biomaghreb
Analyticals (Tunisia). All assessment assays and kits were
performed in accordance with the manufacturers’
instructions and protocols. Lipase activity was measured
on tributyrin using a pH-stat titrator at pH 8 and 37°C as
previously described elsewhere [33].
Histological study
For histological analyses, pieces of pancreas were fixed
in a Bouin solution for 24 h and then embedded in par-
affin. Sections of 5 μm thickness were stained with
hematoxylin-eosin and examined under an Olympus
CX41 light microscope [34,35].
Statistical analysis
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS, Version 10.0).
Data are presented as means ± SD. Determinations were
obtained from eight animals per group, and the differ-
ences were examined using one-way analysis of variance
(ANOVA) followed by the Fisher test (Stat View). Statis-
tical significance was accepted at p< 0.05.
Results
Effect of kombucha on the pancreatic tissue architecture
of diabetic rats
The findings from the histopathological analyses re-
vealed that while the pancreatic tissues of the control
rats (Figure 1A) exhibited normal islets, those of the
alloxan-induced diabetic rats showed clear atrophy of
β-Cells (Figure 1B). The pancreas of the diabetic rats that
were treated either with kombucha or black teas were, on
the other hand, noted to undergo a marked amelioration
(Figure 1C and 1D). Furthermore, the architectures of
the pancreas of the normal rats treated with the kombu-
cha and black teas were noted to be similar to that of the
normal control rats (data not shown).
Plasma and pancreas α-amylase activity and plasma
glucose level
Figure 2 shows that, compared to the their counterparts
from the normal control group, the rats from the control
diabetic rats underwent significant increases in terms of
plasma and pancreas α-amylase activities, which reached
up to 405 ± 53% (p< 0.05) and 225 ± 52% (p< 0.05), re-
spectively. The black tea supplement administered to
diabetic rats was, however, noted to bring about a sig-
nificant decrease in the plasma and pancreas α-amylase
BA
C D
Figure 1 Effect of KT and BT on the histological changes of the
pancreas of the rats evaluated by haematoxylin and eosin
(H&E) staining (100×). (A) Normal control rats (Con) showed
normal β cells. (B) Severe injury in the β-Cells of the pancreas of
diabetic control rats (Diab). (C) and (D) ameliorative action of KT and
BT on the architecture of the pancreas of diabetic rats treated with
BT and KT, respectively.
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(p< 0.05), when compared to untreated diabetic rats.
This inhibitory effect of black tea on α-amylase activity
was followed by a decrease in the rate of blood glucose
that reached up to 65 ± 14% (p< 0.05) (Figure 2C). Con-
siderable α-amylase activity reductions of up to 37 ± 8%
(p< 0.05) and 52 ± 7% (p< 0.05) were also observed in
the plasma and pancreas of the diabetic rats treated
with kombucha, respectively, as compared to those of
the untreated diabetic rats. The kombucha supplement
was also observed to bring about a significant decrease
of 50 ± 11% in terms of blood glucose concentration
(p< 0.05) (Figure 2C).
Plasma and pancreas lipase activity and plasma
lipids concentration
Figure 3 indicates that, when compared to that of non-
diabetic rats, the lipase activity in both the plasma and
pancreas of diabetic rats underwent significant (p< 0.05)
increases of up to 194 ± 35% and 220 ± 41% respectively.
This increase in lipase activity stimulated lipid absorp-
tion and, consequently, led to significant (p< 0.05)
increases of 194 ± 50% and 404 ± 107% (p< 0.05) in the
TG and low-density lipoprotein-cholesterol (LDL-Ch)
concentrations in the plasma, respectively, as compared
to non-diabetic rats (Figure 4). The administration of
black tea to diabetic rats was, on the other hand, noted
to induce significant (p< 0.05) reductions of 80 ± 15%and 68 ± 17% (p< 0.05) in terms of lipase activity in the
plasma and pancreas and of 59 ± 21% and 65 ± 14% in
terms of blood TG and LDL-Ch levels, respectively,
again as compared to those of the untreated diabetic
rats. The administration of kombucha to surviving dia-
betic rats was also observed to have reverted the activity
of lipase in plasma and pancreas back to 68 ± 10% and
62 ± 10% (p< 0.05), respectively. This supplement was,
also, observed to bring about a considerable decrease in
LDL-Ch and TG concentrations in the plasma. More-
over, while diabetes was noted to induce a significant
(p< 0.05) decrease of 58 ± 12% in the plasma HDL-Ch
concentration, black tea and kombucha supplements
were observed to revert this decrease back to 137± 18%
and 157± 30% (p< 0.05), respectively.
Liver-kidney dysfunction indices
Table 1 illustrates that the activities of AST, ALT and
GGT in the plasma of the diabetic rats underwent
significant (p< 0.05) increases of up to 242 ± 35%,
301 ± 35%, and 296 ± 29% respectively, when compared
to non-diabetic rats. The administration of kombucha or
black tea was found to bring about marked decreases in
terms of the three indices of liver toxicity. Moreover,
and when compared to non-diabetic rats, the diabetic
rats were noted to undergo significant (p< 0.05)
increases of 203 ± 17% and 196 ± 15% in terms of the
urea and creatinine rates in the plasma, respectively.
Interestingly, the administration of kombucha and black
tea to diabetic rats was observed to have reverted
this increase back to normal. The findings from histo-
logical analyses further confirmed the positive effect of
those two supplements on the liver and kidney (data
not shown).
Discussion
Although kombucha tea is popular around the world as
a beneficial medicinal health-promoting drink, its benefi-
cial and/or adverse effects on human health have not
been scientifically determined yet. No previous study
has, for instance, so far reported on the systematic inves-
tigation and evaluation of the antidiabetic activity of
kombucha. To the authors’ knowledge, the present work
is the first attempt to investigate the protective effects of
kombucha on diabetes and its complications on the
functions of the liver, kidney, and pancreas.
Several of the enzymes secreted by the pancreas,
namely α-amylase and lipase, are known to break down
dietary polysaccharides and lipids into monosaccharides
and free fatty acids, which represent some of the major
nutrients needed to maintain human health [36,37].
Although most of the research so far conducted on
diabetes has focused on dyslipidemia as a major risk



































































































































































Figure 2 Effect of KT and BT on α-amylase activity in plasma (A), pancreas (B), and blood glucose levels (C) of surviving diabetic rats.
Data represent mean± S.D (n = 8 for each group). The values are statistically significant and presented as follows: single asterisk (*), p< 0.05 vs.
control diabetic rats (Diab); commercial at (@), p< 0.05 vs. respective control rats (Con) [i.e. on the same corresponding tea treatment]; number
sign (#), p< 0.05 vs. diabetic rats treated with BT (Diab + BT).
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pancreatic exocrine function in type 1 and type 2 dia-
betes. The analysis of serum/plasma pancreatic enzymes
was suggested to provide additional informative para-
meters for the assessment of the chronicity and progress
of the illness as well as of the response to therapy [38-41].
The findings of the present study showed that the ad-
ministration of kombucha to surviving diabetic rats sig-
nificantly reduced pancreatic α-amylase activity, which
plays a key role in the digestion of carbohydrates. This
was indicative of lowered levels of absorbable glucose
being formed from the digestion of carbohydrate and
leading to reduced levels of blood glucose. The inhibition
of pancreatic α-amylase activity in the human digestive
tract represents one of the therapeutic approaches com-
monly used for the control and prevention of postpran-
dial hyperglycemia in non-insulin-dependent diabetic
patients through reducing the uptake of glucose released
by those enzymes from starch [42,43].
To produce kombucha, black tea ingredients and
sucrose undergo progressive modifications due to theaction of the tea fungus. Several metabolites can be
identified in the fermented beverage, including acetic,
lactic, gluconic and glucuronic acids, ethanol, glycerol
and polyphenols [20,44-46]. Most of the properties
of kombucha are attributed to the polyphenolic com-
position of the beverage. Tea polyphenolics were
previously reported to inhibit and reduce α-amylase
activity in the in the saliva and intestines of rats,
respectively, which, in turn, were described to lower
the hydrolysis of starch to glucose and to reduce the
assimilation of glucose [47].
The present study also showed that the administration
of kumbucha to surviving diabetic rats reduced pancre-
atic lipase activity, a decrease that is responsible for the
hydrolysis of non-absorbable dietary triglycerides into
absorbable monoglycerides and free fatty acids, which, in
turn, leads to the decrease of plasma cholesterol and TG
level [48-50]. This represents one of the therapeutic
approaches commonly used for the control and preven-
tion of dyslipidemia. Polyphenols were reported to











































































































Figure 3 Effect of KT and BT on lipase activity in plasma (A)
and pancreas (B) of surviving diabetic rats. Data represent
mean± S.D (n = 8 for each group). The values are statistically
significant and presented as follows: single asterisk (*), p< 0.05 vs.
control diabetic rats (Diab); commercial at (@), p< 0.05 vs. respective
control rats (Con) [i.e. on the same corresponding tea treatment];
number sign (#), p< 0.05 vs. diabetic rats treated with BT (Diab + BT).
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chemical structures was required for the enhancement
of pancreatic lipase inhibition [51].
Alloxan is a specific toxin that destroys the pancreatic
β-cells, provoking a state of primary deficiency in insulin
without affecting other types of islets. The diabetic effect
of alloxan is due to an excess in the production of react-
ive oxygen species (ROS). This excess leads to toxicity in
pancreatic cells, which, in turn, reduces the synthesis
and release of insulin while concurrently affecting other
organs, such as liver [52]. Increased lipid peroxidation
products and decreased plasma or tissue concentrations
of superoxide dismutase, catalase, and glutathione havebeen well documented in the literature on alloxan-
induced diabetes [30,53].
Chronic hyperglycemia and dyslipidemia are associated
with a variety of metabolic disorders in human and ani-
mal diabetic patients [54,55], causing oxidative stress,
depleting the activity of the antioxidative defense system,
and resulting in elevated levels of ROS [30,43]. Oxidative
environments might cause the damage of cells and tis-
sues in the liver and kidney [5], which is observed in the
increased levels of AST, ALT, and GGT activities (indices
of liver dysfunction) and of urea and creatinine (indices
of kidney dysfunction). As far as the present study is
concerned, the findings showed that kombucha proved
remarkably efficient in the decrease of the liver and kid-
ney dysfunction indices in surviving diabetic rats,
namely the AST, ALT, and GGT activities and the urea
and creatinine levels. This supplement could, therefore,
be considered as a potential strong candidate for future
industrial application as a therapeutic agent against liver
and kidney toxicity.
Several recent studies have provided ample support
for the strong candidacy of kombucha for application
as an antioxidant agent for the alleviation of oxidative
stress and free radicals as well as the enhancement of
enzymatic defenses. Bhattacharya et al. have, for in-
stance, showed that murine hepatocytes treated with KT
prevented the disruption of mitochondrial membrane
potential and blocked the activation of mitochondria-
dependent apoptotic signaling pathways, thus displaying
a significant reduction of tertiary butyl hydroperoxide-
induced ROS generation and a considerable attenuation
of malonaldehyde levels [20]. The inhibition of radical
species could, therefore, be one of the mechanisms
involved in the efficient hepatoprotective and curative
properties of KT. These findings are, in fact, in good
agreement with the results previously reported by Muru-
gesan et al. showing that KT has the potential to revert
the CCl4-induced hepatotoxicity back through the pro-
duction of antioxidant molecules during fermentation
[17]. The presence of glucaric acid and its derivatives,
as potent detoxifying agents, could also be considered
as another reason for the hepatoprotective effects of
KT [19].
Furthermore, Gharib et al. showed that, owing to its
antioxidant potential, KT can ameliorate trichloroethylene-
induced kidney damage by preventing lipid peroxidation
and ROS species formation [16]. The nephroprotective
effects kombucha were also attributed to organic acids
(e.g. acetic and glucuronic acids) which are known to fa-
cilitate the detoxification process through conjugation with
toxins, which they then solubilise and eliminate from the
body [56].
Kombucha polyphenols may, therefore, prevent the

























































































































































Figure 4 Effect of KT and BT on TG (A), LDL-Ch (B), and HDL-Ch (C) levels in plasma of surviving diabetic rats. Data represent mean± S.D
(n = 8 for each group). The values are statistically significant and presented as follows: single asterisk (*), p< 0.05 vs. control diabetic rats (Diab);
commercial at (@), p< 0.05 vs. respective control rats (Con) [i.e. on the same corresponding tea treatment]; number sign (#), p< 0.05 vs. diabetic
rats treated with BT (Diab + BT).
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Coskun et al. have reported that the administration of
polyphenols, such as quercetin and epicatechin, to sur-
viving diabetic rats protects the architecture of pancre-
atic β-cells, preserves the secretion of insulin, and
stimulates the regeneration of this type of cells [57]. The
administration of an antioxidant-rich beverage, such as
kombucha, to diabetic rats would, therefore, presumably
decrease the ROS-mediated toxicity in pancreatic β-cellsTable 1 Effect of KT and BT on liver-kidney dysfunction indic
Con Con+BT Co
Liver dysfunction indices
AST (U/L) 32 ± 2.37* 31.67 ± 3.56* 2
ALT (U/L) 24.25 ± 2.79* 23.33 ± 4.13* 21
GGT (U/L) 15.67 ± 2.73* 16.50 ± 4.76* 13
Kidney toxicity indices
Creatinine (mg/L) 13.02 ± 1.42* 12 ± 2.19* 9
Urea (g/L) 0.52 ± 0.07* 0.5 ± 0.09* 0
Data represent mean ± S.D (n = 8 for each group). The values are statistically presen
commercial at (@), p< 0.05 vs. respective control rats (Con) [i.e. on the same corres[35]. The ability of kombucha to reduce the blood glu-
cose level could also be attributed to its ability to modu-
late the immune system [18], leading to the decrease of
β-cell damages. It is worth noting that the findings indi-
cated that the curative effects achieved with the adminis-
tration of KT were more pronounced than those
reported for BT, which could presumably be attributed
to the large amounts of polyphenols and flavonoids
present in KT as compared to black tea [20]. In fact,es in plasma of surviving diabetic rats
n+KT Diab Diab+BT Diab+KT
9.5 ± 3.02* 77.17 ± 9.35 52.58 ± 23.75 47.75 ± 36.14
.33 ± 4.13* 72.33 ± 5.47 41.67 ± 5.16*@ 36.9 ± 10.68*@
.67 ± 1.63* 45.83 ± 6.15 26.83 ± 6.40*@ 23.67 ± 5.88*
.83 ± 1.47* 25.5 ± 2.59 18.83 ± 2.86*@ 15.4 ± 2.59*
.47 ± 0.06* 1.05 ± 0.11 0.77 ± 0.36* 0.63 ± 0.25*
ted as follows: single asterisk (*), p< 0.05 vs. control diabetic rats (Diab);
ponding tea treatment].
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of kombucha are needed to fully appreciate its values
and limitations.
Conclusions
Overall, the present study demonstrated that the hy-
poglycemic and antilipidemic activities exhibited by
kombucha tea were effective enough to alleviate alloxan-
induced diabetes in experimental rats. The beneficial
effect of dietary kombucha is presumably attributed to
its potent hypoglycemic and antilipidemic properties, as
well as antioxidant potential. Further studies are obvi-
ously needed to capitalize on the protective effects of
kombucha tea in humans and to make its use suitable as
an effective functional food with therapeutic potential.
The findings presented in this work are encouraging and
substantiate the search for newer pharmacophores in
kombucha behind the hypoglycemic and antilipidemic
effects. The possible mechanisms underlying the inhib-
ition of pancreatic α-amylase and lipase are also yet to
be studied.
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